Announced
Completed
Skylake Equity Partners and Crescendo Equity Partners led a $140m funding round in MEDIPOST.
Synopsis
Investment companies Skylake Equity Partners and Crescendo Equity Partners led a $140m funding round in MEDIPOST, a biotechnology company developing allogeneic, umbilical cord blood-derived stem cell therapies.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2026 Datasite